Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “COVID-19”

LIPId Profile Changes in Inflammatory Conditions Induced by SARS-CORoronavirus-2Completed
NCT05113836N/AUpdated Aug 12, 2026
Sponsor: Assistance Publique - Hôpitaux de Paris
SARS-CoV2 Infection
France
COVID-19, Chronic Adaptation and Response to Exercise (COVID-CARE)Active Not Recruiting
NCT04595773NAUpdated Aug 12, 2026
Sponsor: National Institutes of Health Clinical Center (CC)
COVID-19
United States
Efficacy and Safety of BIO101 in the Prevention of Respiratory Deterioration in Hospitalized COVID-19 PatientsTerminated
NCT04472728Phase 2, Phase 3Updated Aug 12, 2026
Sponsor: Biophytis
Covid-19 · SARS-CoV2
United States, Belgium, Brazil, France, Puerto Rico
Positron Emission Tomography (PET) Imaging of Neuroinflammation in Patients With Neurological Dysfunction After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2) InfectionRecruiting
NCT05656105EARLY_Phase 1Updated Aug 12, 2026
Sponsor: University of Alabama at Birmingham
SARS CoV-2 Post-Acute Sequelae
United States
RADx-UP Phase 3D (Oregon Saludable: Juntos Podemos)Completed
NCT05910879NAUpdated Aug 12, 2026
Sponsor: University of Oregon
Health Behavior · Health Care Utilization · Vaccine Hesitancy
United States
A Study on Paxlovid Once in the Market, to Observe Its Safety and Effectiveness in Patients Who Have a High Chance of Getting Severe COVID-19Recruiting
NCT05890612N/AUpdated Aug 12, 2026
Sponsor: Pfizer
COVID-19
South Korea
RECOVER-NEURO: Platform Protocol, Appendix_A to Measure the Effects of BrainHQ, PASC CoRE and tDCS Interventions on Long COVID SymptomsCompleted
NCT05965739NAUpdated Aug 11, 2026
Sponsor: Duke University
Long COVID · Long Covid19 · Long Covid-19
United States
An Online Game to Help Canadian Adults Identify COVID-19 Vaccine Misinformation With One-Month Follow-UpCompleted
NCT07758296NAUpdated Aug 11, 2026
Sponsor: University of South Carolina
COVID-19 · Vaccination Hesitancy · Health Misinformation · Communication
United States
Cognitive Rehabilitation in Post-COVID-19 ConditionActive Not Recruiting
NCT05494424NAUpdated Aug 11, 2026
Sponsor: Lovisenberg Diakonale Hospital
COVID-19
Norway
Virtual Tai Chi in Older University WorkersCompleted
NCT07757516NAUpdated Aug 11, 2026
Sponsor: University of Arizona
Sleep Quality
United States
Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer PatientsTerminated
NCT05101213Phase 1Updated Aug 11, 2026
Sponsor: M.D. Anderson Cancer Center
Adenovirus Infection · BK Virus Infection · Cytomegaloviral Infection · Hematopoietic and Lymphoid Cell Neoplasm
United States
A Study of Baricitinib (LY3009104) in Children With COVID-19Terminated
NCT05074420Phase 3Updated Aug 11, 2026
Sponsor: Eli Lilly and Company
Covid19 · Corona Virus Infection
United States, Brazil, Mexico, Spain
Online Games to Help Canadian and U.S. Adults Identify COVID-19 and Vaccine Misinformation: Three Sequential Randomized StudiesCompleted
NCT07758309NAUpdated Aug 11, 2026
Sponsor: University of South Carolina
COVID-19 · Vaccine Hesitancy · Health Misinformation · Communication
United States
"Artificial Intelligence-Based Data Analysis Results and Mortality Prediction in Covid-19 Patients in Intensive Care"Completed
NCT06795880N/AUpdated Aug 11, 2026
Sponsor: Kocaeli City Hospital
COVID-19
Turkey (Türkiye)
Epigenetic Changes in Long COVID PatientsNot Yet Recruiting
NCT07757620N/AUpdated Aug 11, 2026
Sponsor: Istituti Clinici Scientifici Maugeri SpA
Long COVID-19 Syndrome · Long COVID Symptoms
Italy
MultiStem Administration for COVID-19 Induced ARDS (MACoVIA)Terminated
NCT04367077Phase 2, Phase 3Updated Aug 11, 2026
Sponsor: Healios K.K.
ARDS
United States
Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 InfectionCompleted
NCT04481633NAUpdated Aug 10, 2026
Sponsor: University Hospital, Toulouse
COVID-19
France
Comparison of the ID NOW and Accula Point-of-Care Assays for Detection of COVID-19Withdrawn
NCT04403035N/AUpdated Aug 10, 2026
Sponsor: Henry Ford Health System
Covid-19
United States
The Impact of COVID-19 on Pulmonary ProceduresRecruiting
NCT05022446N/AUpdated Aug 10, 2026
Sponsor: M.D. Anderson Cancer Center
COVID-19 Infection · Hematopoietic and Lymphoid Cell Neoplasm · Malignant Solid Neoplasm
United States
Autoimmune Intervention Mastery Course StudyActive Not Recruiting
NCT05057676NAUpdated Aug 10, 2026
Sponsor: Terry L. Wahls
Multiple Sclerosis · Clinically Isolated Syndrome · Fibromyalgia · Post Acute Sequelae of COVID-19
United States
Can Vitamin D Reduce the Burden of COVID-19?Completed
NCT07128069NAUpdated Aug 7, 2026
Sponsor: University of Chicago
COVID-19
United States
Viral Infections in Healthy and Immunocompromised HostsRecruiting
NCT01306084N/AUpdated Aug 7, 2026
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Anogenital Herpes · COVID-19 · Herpes Labialis
United States
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of AgeRecruiting
NCT07730450Phase 4Updated Aug 7, 2026
Sponsor: BioNTech SE
COVID-19 Vaccines
United States
A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That Are Considered at Higher Risk of Severe COVID-19Completed
NCT07222384Phase 3Updated Aug 7, 2026
Sponsor: BioNTech SE
COVID-19 · SARS-COV-2 Infection
United States, Puerto Rico
A Study of the EMPOWER Program for Latinx Caregivers of ICU PatientsWithdrawn
NCT05589883NAUpdated Aug 7, 2026
Sponsor: Memorial Sloan Kettering Cancer Center
Informal Caregiver

Previous page Next page